- Home
- ANEB vs FTHM Comparison
ANEB vs FTHM Comparison
Compare ANEB & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- FTHM
- Stock Information
- Founded
- ANEB 2020
- FTHM 2010
- Country
- ANEB United States
- FTHM United States
- Employees
- ANEB N/A
- FTHM N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- FTHM Real Estate
- Sector
- ANEB Health Care
- FTHM Finance
- Exchange
- ANEB Nasdaq
- FTHM Nasdaq
- Market Cap
- ANEB 111.8M
- FTHM 54.7M
- IPO Year
- ANEB 2021
- FTHM 2020
- Fundamental
- Price
- ANEB $2.64
- FTHM $1.43
- Analyst Decision
- ANEB Buy
- FTHM Strong Buy
- Analyst Count
- ANEB 2
- FTHM 1
- Target Price
- ANEB $8.00
- FTHM $2.50
- AVG Volume (30 Days)
- ANEB 20.2K
- FTHM 231.2K
- Earning Date
- ANEB 11-14-2025
- FTHM 11-11-2025
- Dividend Yield
- ANEB N/A
- FTHM N/A
- EPS Growth
- ANEB N/A
- FTHM N/A
- EPS
- ANEB N/A
- FTHM N/A
- Revenue
- ANEB N/A
- FTHM $390,032,000.00
- Revenue This Year
- ANEB N/A
- FTHM $25.22
- Revenue Next Year
- ANEB N/A
- FTHM $16.19
- P/E Ratio
- ANEB N/A
- FTHM N/A
- Revenue Growth
- ANEB N/A
- FTHM 19.16
- 52 Week Low
- ANEB $0.80
- FTHM $0.65
- 52 Week High
- ANEB $3.42
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- ANEB 55.13
- FTHM 37.74
- Support Level
- ANEB $2.50
- FTHM $1.54
- Resistance Level
- ANEB $2.76
- FTHM $1.84
- Average True Range (ATR)
- ANEB 0.13
- FTHM 0.15
- MACD
- ANEB 0.00
- FTHM -0.02
- Stochastic Oscillator
- ANEB 61.82
- FTHM 10.91
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.